Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Ischemic Heart Disease

  Free Subscription


18.05.2026

2 Am Heart J
2 Am J Cardiol
2 Am J Med
1 Angiology
2 Ann Thorac Surg
1 Arterioscler Thromb Vasc Biol
2 BMJ
1 Can J Cardiol
18 Catheter Cardiovasc Interv
1 Circ Cardiovasc Interv
1 Circulation
1 Clin Cardiol
2 Clin Chem
2 Eur Heart J
2 Heart
3 Int J Cardiol
3 J Am Coll Cardiol
2 J Electrocardiol
3 JAMA
2 Mol Cell Biochem
5 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. WANG W, Gu Y, Wang D, Zhang W, et al
    High-Intensity Interval Training Combined with Moderate-Intensity Continuous Training in Post-PCI Acute Myocardial Infarction Patients: A Randomized Controlled Trial.
    Am Heart J. 2026 May 8:107472. doi: 10.1016/j.ahj.2026.107472.
    PubMed         Abstract available

  2. ANDERSON JL, May HT, Winslow T, Le VT, et al
    CorCal Outcomes: a Randomized Trial using the Pooled Cohort Equation or Coronary Artery Calcium to Select Statin Therapy in Primary Prevention Patients. Study Design and Baseline Characteristics.
    Am Heart J. 2026 May 7:107473. doi: 10.1016/j.ahj.2026.107473.
    PubMed         Abstract available


    Am J Cardiol

  3. PARK EJ, Kang DO, Lee JS, Lee J, et al
    Long-Term Clopidogrel versus Aspirin Monotherapy After Drug-Eluting Stent Implantation: A Nationwide Real-World Comparative Study.
    Am J Cardiol. 2026 May 6:S0002-9149(26)00336.
    PubMed         Abstract available

  4. AKBAR UA, Mondal A, Vorla M, Alruwaili W, et al
    Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Outcomes in Patients With Atherosclerotic Cardiovascular Disease and Obesity Without Diabetes.
    Am J Cardiol. 2026 May 6:S0002-9149(26)00335.
    PubMed         Abstract available


    Am J Med

  5. NARDIN M, Mehran R, Oliva A, Kedhi E, et al
    From obesity to cardiovascular disease: pathological basis and clinical implications.
    Am J Med. 2026 May 7:S0002-9343(26)00382-7. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available

  6. LI X, Wang S, Wang J, Ji Y, et al
    Circulating Apolipoprotein E concentration and incident cardiovascular diseases: evidence from an electronic health record-based cohort.
    Am J Med. 2026 May 6:S0002-9343(26)00376-1. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Angiology

  7. PAN Y, Chen X, Qiu L, Yin C, et al
    Correlation Between Ultrasound-Based Carotid Plaque Characteristics and Coronary Artery Disease Severity: A Retrospective Cross-Sectional Study.
    Angiology. 2026 May 10:33197261447010. doi: 10.1177/00033197261447010.
    PubMed         Abstract available


    Ann Thorac Surg

  8. HAWKINS RB, Kubi B, Strobel RJ, Paneitz DC, et al
    Long-Term Outcomes of Paroxysmal and Persistent Atrial Fibrillation Management Strategy During Non-Emergent Coronary Artery Bypass Surgery.
    Ann Thorac Surg. 2026 May 13:S0003-4975(26)00444.
    PubMed         Abstract available

  9. YU PJ, Newman J, Chang SC, Habib RH, et al
    Optimal Management for Moderate Aortic Stenosis at the Time of Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2026 May 13:S0003-4975(26)00440.
    PubMed         Abstract available


    Arterioscler Thromb Vasc Biol

  10. RAMASAMY A, Sivananthan A, Tanboga IH, Kumaran S M T, et al
    Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.
    Arterioscler Thromb Vasc Biol. 2026 May 14. doi: 10.1161/ATVBAHA.126.324466.
    PubMed         Abstract available


    BMJ

  11. YUAN X, Li J, Lei L, Zhang L, et al
    Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial.
    BMJ. 2026;393:e088939.
    PubMed         Abstract available

  12. RAJA SG
    Optimising antiplatelet therapy after coronary artery bypass grafting.
    BMJ. 2026;393:s815.
    PubMed        


    Can J Cardiol

  13. WANG J, Gao W, Wang Z, Zhang F, et al
    Dynamic Changes and Prognostic Value of Angio-derived Index of Microcirculatory Resistance in Acute Myocardial Infarction: A Cohort Study.
    Can J Cardiol. 2026 May 13:S0828-282X(26)00406.
    PubMed         Abstract available


    Catheter Cardiovasc Interv

  14. ONISHI K, Yasuda M, Yamada N, Soejima N, et al
    Predicting Coronary Occlusion Risk during Redo-TAVR at First TAVR: Asymmetric Calcification Causes Failure.
    Catheter Cardiovasc Interv. 2026;107:1692-1700.
    PubMed         Abstract available

  15. SHIBATA N, Morita Y, Kanzaki Y, Watanabe N, et al
    Coronary Perforation and Late Pseudoaneurysm Outcomes After Excimer Laser Angioplasty.
    Catheter Cardiovasc Interv. 2026;107:2050-2059.
    PubMed         Abstract available

  16. BESNARD A, Djebbar M, Akodad M, Amour J, et al
    Emergency Mitral Transcatheter Edge-to-Edge Repair as a Bridge to Surgical Mitral Valve Replacement in Cardiogenic Shock: A Case Report.
    Catheter Cardiovasc Interv. 2026 Mar 25. doi: 10.1002/ccd.70578.
    PubMed         Abstract available

  17. HOLCK EN, Vadala G, Ayoub M, Gorgulu S, et al
    Procedural Outcome of Modern Percutaneous Coronary Intervention in Proximal Chronic Total Occlusions.
    Catheter Cardiovasc Interv. 2026 Mar 25. doi: 10.1002/ccd.70565.
    PubMed         Abstract available

  18. BITAR F, Abou-Karam R, Gady S, Thrompson AG, et al
    Diagnostic Yield and Testing Characteristics of an Invasive Coronary Function Testing Program.
    Catheter Cardiovasc Interv. 2026;107:2022-2031.
    PubMed         Abstract available

  19. PONNADA RB, Shah AK, Pujari B, Bhagwat AM, et al
    Protected Percutaneous Coronary Intervention With Impella 5.5 Pump in Severe Peripheral Artery Disease.
    Catheter Cardiovasc Interv. 2026 Mar 22. doi: 10.1002/ccd.70566.
    PubMed         Abstract available

  20. MIKS CD, Ozaki GK, Shukla CR, Sharma V, et al
    Intravascular Lithotripsy Is Associated With Superior Clinical Outcomes Compared to Atherectomy: A Large-Scale, Propensity-Matched Analysis.
    Catheter Cardiovasc Interv. 2026;107:1934-1944.
    PubMed         Abstract available

  21. TSIAMIS N, Tsakirian F, Papanikolaou A, Afendoulis D, et al
    Revolutionizing Modern Percutaneous Coronary Intervention: Drug-Coated Balloons for Diabetics With Small Vessel Disease. A Narrative Review.
    Catheter Cardiovasc Interv. 2026 Mar 15. doi: 10.1002/ccd.70550.
    PubMed         Abstract available

  22. KIM YL, Noh HW, Seo CO, Park JR, et al
    Plaque Morphology-Dependent Regression of Tandem Coronary Plaques Under Intensive Lipid-Lowering Therapy.
    Catheter Cardiovasc Interv. 2026;107:1917-1921.
    PubMed         Abstract available

  23. GHERASIE FA, Ungureanu C
    Successful Management of a Complex Coronary Bifurcation Lesion in Acute Coronary Syndrome Using a Free-Metal Approach.
    Catheter Cardiovasc Interv. 2026;107:1899-1901.
    PubMed         Abstract available

  24. LEIBUNDGUT G, Bilal Iqbal M, Ungureanu C, Barmpas A, et al
    Excessive Ostial Stent Protrusion: Evaluation of Management Strategies and Clinical Outcomes of the Side Flap Technique.
    Catheter Cardiovasc Interv. 2026;107:1884-1898.
    PubMed         Abstract available

  25. NOORI M, Christiansen EH, Hougaard M, Eftekhari A, et al
    Long-Term Outcomes After Percutaneous Coronary Intervention With the Polymer-Free Biolimus-Coated BioFreedom Stent Versus the Biodegradable-Polymer Sirolimus-Eluting Orsiro Stent in Patients With Acute Coronary Syndromes.
    Catheter Cardiovasc Interv. 2026 Mar 9. doi: 10.1002/ccd.70549.
    PubMed         Abstract available

  26. LIO V, Barbero U, Drago S, Persampieri S, et al
    Sheathless Femoral Impella Implantation: A Safer Hemodynamic Support in High-Risk PCI and Cardiogenic Shock.
    Catheter Cardiovasc Interv. 2026;107:1819-1825.
    PubMed         Abstract available

  27. MARCHETTA M, Paragliola V, Benedetto D, Sasso S, et al
    Drug-Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes.
    Catheter Cardiovasc Interv. 2026 Mar 3. doi: 10.1002/ccd.70542.
    PubMed         Abstract available

  28. KHALAF Y, Atta S, Helal A, Bashir A, et al
    Survival Beyond the Odds: Twelve-Week Follow-Up After Conservative Management of Post-Infarction Ventricular Free Wall Rupture.
    Catheter Cardiovasc Interv. 2026;107:1791-1795.
    PubMed         Abstract available

  29. CHANG CC, Lee JY, Chou HL, Sung WT, et al
    Physiologic Assessment Using Angiography-Derived Fractional Flow Reserve After Drug-Coated Balloon Angioplasty in De Novo Coronary Lesions.
    Catheter Cardiovasc Interv. 2026 Feb 24. doi: 10.1002/ccd.70527.
    PubMed         Abstract available

  30. MATSUHIRO Y, Egami Y, Nohara H, Kawanami S, et al
    Differences in Vascular Responses and Underlying Mechanisms Following Paclitaxel-Coated Balloon Angioplasty Between Lipid-Rich and Non-Lipid-Rich Lesions in Chronic Coronary Syndrome.
    Catheter Cardiovasc Interv. 2026;107:1732-1742.
    PubMed         Abstract available

  31. SHIN ES, Kim S, Kang DO, Choi BJ, et al
    Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Patients With High-Bleeding Risk.
    Catheter Cardiovasc Interv. 2026;107:1709-1717.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  32. PRICE MJ, Budrys P, Baranauskas A, Toth-Gayor G, et al
    Laser- and Optics-Based Intravascular Lithotripsy for the Treatment of Calcified Coronary Stenoses: The RESTORE First-In-Human Study.
    Circ Cardiovasc Interv. 2026 May 11:e016874.
    PubMed        


    Circulation

  33. RUEL M, Sandner S, Ponnambalam M, Brown C, et al
    Secondary Prevention After Coronary Artery Bypass Graft Surgery: 2026 Update: A Scientific Statement From the American Heart Association.
    Circulation. 2026 May 13. doi: 10.1161/CIR.0000000000001434.
    PubMed         Abstract available


    Clin Cardiol

  34. FAN X, Zhou T, Li F, Shi G, et al
    Hand Dysfunction After Intervention via Distal Versus Conventional Transradial Access: A Meta-Analysis of Randomized Trials.
    Clin Cardiol. 2026;49:e70350.
    PubMed         Abstract available


    Clin Chem

  35. RESTAN IZ, Tew YY, Steiro OT, Li Z, et al
    Exploring Sex-Specific High-Sensitivity Cardiac Troponin Thresholds for Rule-Out of Non-ST-Elevation Myocardial Infarction.
    Clin Chem. 2026 May 15:hvag030. doi: 10.1093.
    PubMed         Abstract available


  36. Correction to: Cardiac Biomarker Kinetics in Patients after Coronary Artery Bypass Grafting with an Uncomplicated Course.
    Clin Chem. 2026 May 12:hvag054. doi: 10.1093.
    PubMed        


    Eur Heart J

  37. HOLMGREN L, von Koch S, Andell P, Sorensson P, et al
    Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease.
    Eur Heart J. 2026 May 11:ehag216. doi: 10.1093.
    PubMed         Abstract available

  38. LORUSSO R, Matteucci M, Ronco D, Massimi G, et al
    Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction.
    Eur Heart J. 2026 May 11:ehag164. doi: 10.1093.
    PubMed         Abstract available


    Heart

  39. TSAI TY, Aldujeli A, Haq A, Murphy P, et al
    Diagnostic performance of exercise stress testing findings and coronary microvascular dysfunction in patients with angina with non-obstructive coronary artery disease.
    Heart. 2026;112:615-623.
    PubMed         Abstract available

  40. KIVIMAKI K, Rankinen J, Lyytikainen LP, Pohjantahti H, et al
    Frontal T-wave axis deviation and risk of sudden cardiac death in coronary syndromes.
    Heart. 2026;112:598-605.
    PubMed         Abstract available


    Int J Cardiol

  41. KROLL C, Hubert A, Saccardi L, Martinez Pereyra V, et al
    (Long-term) efficacy of endotype-based drug therapy on quality of life and symptom management in coronary vasomotion disorders.
    Int J Cardiol. 2026;456:134518.
    PubMed         Abstract available

  42. GIOVACHINI L, Ferrante A, Guedeney P, Rahoual G, et al
    Impacts of stent characteristics on periprocedural ischemic events in elective PCI: the ALPHEUS-stents study.
    Int J Cardiol. 2026;456:134506.
    PubMed         Abstract available

  43. GADELMAWLA AF, Taha AM, Alkuwaiti FA, Alkuwaiti MA, et al
    Prognostic impact of persistent microvascular obstruction on cardiac magnetic resonance after STEMI: A systematic review and meta-analysis.
    Int J Cardiol. 2026;456:134523.
    PubMed         Abstract available


    J Am Coll Cardiol

  44. MEHRAN R
    A Window Closed, A World Opened: Leadership, Legacy, and the Future of Cardiovascular Care.
    J Am Coll Cardiol. 2026 May 13:S0735-1097(26)06348.
    PubMed        

  45. CLARK MG, Levin MG
    Polygenic Risk Scores for Cardiovascular Disease: Closing the Gap Between Prediction and Practice.
    J Am Coll Cardiol. 2026 May 13:S0735-1097(26)06012.
    PubMed        

  46. SCHAFFER JM, Shih E, Squiers JJ, Banwait JK, et al
    Multiarterial Grafting and Survival After Coronary Artery Bypass Grafting: An Instrumental Variable Analysis.
    J Am Coll Cardiol. 2026 May 13:S0735-1097(26)05875.
    PubMed         Abstract available


    J Electrocardiol

  47. GORGELS APM
    The electrophysiologic continuum of occlusion myocardial infarction.
    J Electrocardiol. 2026;96:154271.
    PubMed         Abstract available

  48. SETOGUCHI T, Matsumoto N, Matsunaga Y, Otsuka N, et al
    Comparison of measured and synthesized right-sided precordial electrocardiograms in patients with right ventricular infarction.
    J Electrocardiol. 2026;97:154273.
    PubMed         Abstract available


    JAMA

  49. LIU X, Zhang F, Zhang C, Li Z, et al
    Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial.
    JAMA. 2026 May 8:e265245. doi: 10.1001/jama.2026.5245.
    PubMed         Abstract available


  50. Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: Research Summary.
    JAMA. 2026 May 8:e265288. doi: 10.1001/jama.2026.5288.
    PubMed        

  51. ANDERER S
    Syphilis Linked to Higher Risk of Some Cardiovascular Outcomes.
    JAMA. 2026 May 8. doi: 10.1001/jama.2026.2132.
    PubMed        


    Mol Cell Biochem

  52. FENG N, Zhang A, Yao L, Tang J, et al
    Puerarin alleviates myocardial ischemia-reperfusion injury by enhancing FUNDC1-mediated mitophagy.
    Mol Cell Biochem. 2026 May 12. doi: 10.1007/s11010-026-05567.
    PubMed         Abstract available

  53. HUANG Z, Chen X, Ren J, Wan L, et al
    Dose- and time-dependent cardioprotection of liproxstatin-1 via sequential modulation of ferroptosis pathways after myocardial ischemia-reperfusion.
    Mol Cell Biochem. 2026 May 13. doi: 10.1007/s11010-026-05543.
    PubMed         Abstract available


    N Engl J Med

  54. CACOULIDIS C
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2026;394:1964.
    PubMed        

  55. FAUCHIER L, Guglieri M
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents.
    N Engl J Med. 2026;394:1964-1965.
    PubMed        

  56. LEE SJ, Yu HT, Kim JS
    Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents. Reply.
    N Engl J Med. 2026;394:1965-1966.
    PubMed        

  57. HINGORANI AD, Wald NJ
    The Inherited Basis of Coronary Artery Disease.
    N Engl J Med. 2026;394:1966-1967.
    PubMed        

  58. SCHUNKERT H, Natarajan P, Samani NJ
    The Inherited Basis of Coronary Artery Disease. Reply.
    N Engl J Med. 2026;394:1967-1968.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum